Tenaya Therapeutics Inc.

12/17/2024 | Press release | Distributed by Public on 12/17/2024 06:08

Tenaya Therapeutics Reports Promising Early Data from MyPEAK™ 1 Phase 1b/2 Clinical Trial of TN 201 for Treatment of MYBPC3 Associated Hypertrophic Cardiomyopathy

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.